NCT03873350

Brief Summary

The purpose of the project is to investigate if consumption of the fermented tea beverage kombucha has an effect on the gut and/or oral microbiota, and further if it depends on the content of living bacteria or is inherent even to sterilized kombucha. This will be studied by a clinical trial in which healthy individuals will be given living kombucha, sterilized kombucha or water. The participants will consume one bottle (33 cl) of their designated drink per day for 21 days. Fecal and saliva samples will be collected before, directly and ten days after the intervention. These will then be examined to see if there is a change in the micro flora due to the kombucha.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2018

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 2, 2018

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 4, 2018

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

March 11, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 13, 2019

Completed
Last Updated

March 13, 2019

Status Verified

March 1, 2019

Enrollment Period

1 month

First QC Date

March 11, 2019

Last Update Submit

March 12, 2019

Conditions

Keywords

Microbiota colonization kombucha bacteria yeast

Outcome Measures

Primary Outcomes (1)

  • The primary outcome is a change in the composition of the gut of oral micro flora, measured by extraction and sequencing of genetic material in fecal and saliva samples.

    A library will be created using Illumina sequencing that will enable comparing the microbiological composition before and after the intervention.

    Samples will be collected before, directly after and ten days after the end of the intervention.

Secondary Outcomes (1)

  • The secondary outcome of the study is to be able to re-isolate a species from the kombucha in the collected samples after the intervention.

    Samples will be collected before, directly after and ten days after the intervention. The kombucha culture is studied before the intervention.

Study Arms (3)

Living kombucha

EXPERIMENTAL
Other: Consumption of kombucha

Heat-sterilized kombucha

PLACEBO COMPARATOR
Other: Consumption of heat-sterilized kombucha

Water

NO INTERVENTION

Interventions

The intervention performed in the study implies letting healthy individuals consume one bottle (33 cl) of living kombucha daily for three weeks.

Living kombucha

The intervention performed in the study implies letting healthy individuals consume one bottle (33 cl) of heat-sterilized kombucha daily for three weeks.

Heat-sterilized kombucha

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The participants should be above 18 years of age.
  • The participants must live in proximity of Lund or Helsingborg to be able to leave samples collected.
  • The participants should consider themselves healthy and have no gut or stomach problems.

You may not qualify if:

  • The participants should not be diagnosed with any gut or stomach diseases or problems.
  • The participants cannot consume any food with living microorganisms two weeks before, during of ten days after the intervention.
  • Participants cannot use anti-microbial oral products during the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lund University

Lund, Skåne County, 22100, Sweden

Location

MeSH Terms

Conditions

Communicable Diseases

Condition Hierarchy (Ancestors)

InfectionsDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
The participants will be masked, meaning they will not know if they are given living or sterilized kombucha. The control group consuming water will know that they are the control group.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: The participants will be divided into three groups in which one is given living kombucha, one heat-sterilized kombucha (placebo group) and one regular tap water (control group).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant university lecturer at the Department of Food Technology, Lund University

Study Record Dates

First Submitted

March 11, 2019

First Posted

March 13, 2019

Study Start

April 1, 2018

Primary Completion

May 2, 2018

Study Completion

May 4, 2018

Last Updated

March 13, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share

No plan to share participant data.

Locations